New breast cancer solution tested in St. Pete

New breast cancer solution tested in St. Pete April 15, 2016, 10:39

Biocad, an innovative developer in St. Petersburg, continues a series of tests for its new breast cancer solution. The drug candidate is expected to show efficacy in fighting the disease at both early and advanced stages.

The new candidate is capable of blocking two receptors simultaneously, the biotech company said-not only the HER2 receptors most of the solutions available in the market currently target, but also the HER3 receptor. By linking up with the HER2, the HER3 is said to spur tumor growth and metastases considerably, while rendering treatment with monospecific anti-HER2 antibodies ineffective.

Biocad hopes the drug will hit the market in 2020.

As the St. Pete researchers noted, in spite of a large number of breast cancer solutions currently available in the market, including those specifically targeting the HER2 receptor, such as trastuzumabum, there’s been little improvement reported so far. In most cases, this therapy produces little or no result because tumors are just resistant to drugs.

What Biocad has come up with is one of the first-ever monoclonal antibodies to be able to suppress the mechanisms of drug resistance development in a tumor and effectively impact tumors that are known for lack of responsiveness to trastuzumabum, the Russian developers said.

The drug candidate has been reportedly developed using sophisticated methods of mathematical modeling, enabling the researchers to pick what are thought to be most effective and safe molecules from Biocad’s vast immune libraries, and turn them into future drugs.

Breast cancer accounts for 17% of all cancer cases in Russian women, which makes it number one oncologic killer of female patients in this country.

Source: http://marchmontnews.com/Technology-Innovation/North-West/21423-New-breast-cancer-solution-tested-St...

cancer

or on to add a comment to scientific problem you are interested in!

Comments (0)

You may also be interested in

A little video game-playing 'linked with better-adjusted children'

A new study suggests video game-playing for less than an hour a day is linked with better-adjusted children and teenagers. The research, carried out by Oxford University, found that young people who indulged in a little video game-playing were associated with being better adjusted than those who had never played or those who were on video games for three hours or more. The study finds no positive or negative effects for young people who played ‘moderately’ between one to three hours a day. However, the study, published in the journal, Pediatrics, suggests that the influence of video games on children, for good or for ill, is very small when compared with more ‘enduring’ factors, such as whether the child is from a functioning family, their school relationships, and whether they are materially deprived.

Database

The database will assist you in finding companies, investors, research institutes and research centers of aging. We provide full information on public and private companies. According to our plan platform will give access to the world of projects seeking capital to analysts of the leading specialists in online communities, as well as to the global list of investors.

Fundraising

Raise funds necessary for successful work of your company, venture project or your idea.